see that physicians practising in centres of excellence remain enthusiastic about such techniques.
On the subject offlupenthixol, the ABPI Data Sheet Compendium 1987, states that; 'Clinical trials have shown symptoms of apathy, lowered mood, asthenia; despondency, lack of initiative and inertia are likely to respond well to flupenthixol and that its high therapeutic index is an advantage in view of the suicide risk associated with depressive illness.' My colleagues and I have used flupenthixol in mild depressive conditions in general practice at doses of 0.5-1 mg daily in short courses (usually lasting less than 6 weeks) and have found no problems with tardive dyskinesia. We would, of course, acknowledge that larger doses used for longer periods of time may lead to such problems. I feel, however, that our paper does highlight all these points and emphasizes the low dosage and the duration of courses of treatment. G I HACKETT Health Centre, Holmes Chapel, Cheshire
The anion gap as a screening procedure for occult myeloma in the elderly Sir, Flanagan et al. (January 1988 JRSM, p 27) propose the use of the anion gap as a screening test for the early diagnosis of myeloma in the elderly. Any screening test should be cheap, specific and sensitive. As indicated by Flanagan et al. the determination of the anion gap by calculation has no intrinsic cost, but this only holds true if the population being screened is already having plasma electrolyte determinations for some other reason. It also assumes that plasma chloride is among the parameters being profiled, which is by no means always the case.
If a test has high specificity and sensitivity, by definition its use should result in few false positive and false negative categorizations. Any cause of hypoproteinaemia may be associated with a reduced anion gap in the absence of myeloma. In addition, the overlapping distributions of anion gaps in the healthy population and in patients with myeloma, and particularly those patients with IgA paraproteinaemia, would make it difficult to interpret a 'normal' result. Because the depressed anion gap, in some patients with myeloma, is in part dependent on the magnitude of the paraproteinaemia, early disease may easily be missed.
The authors mention other simple haematological screening tests for myeloma, including ESR and background staining as a blood film, but they fail to discuss the use of simple and cheap biochemical indices, such as the measurement of serum total protein and albumin.
Renal impairment is a common feature of malignant paraproteinaemia. The associated increase in anion gap would tend to off-set the reduction related to the myeloma, and would therefore be a cause for a false negative result. Flanagan et al. do not mention what proportion of their patient group was so affected.
Elderly subjects do indeed have a high prevalence of myeloma, and perhaps they should be screened for this disease. However, estimation of total serum protein and albumin, with a derived estimate of serum gamma-globulins, followed by serum protein electrophoresis and immunofixation, would appear to be the most logical diagnostic approach.
G FERNS

Senior Research Fellow University of Washington, USA
Sir, Flanagan et al. (January 1988 JRSM, p 27) suggest that the anion gap may be useful as a screening test for myeloma in the elderly, and that this procedure has no intrinsic cost.
The predictive value of a low anion gap for myeloma is not given, but can be calculated from published datal using Bayes' theorern'', The probability of myeloma in the general population of Cumbria is 0.00026 3 . If every patient with this disease has a low anion gap, this can be compared to the probability of a low anion gap occurring from other causes. A study of 39 360 patients' found a low anion gap at least once in 304 (probability=0.0077) including one case of myeloma. Thus the probability of a patient with a low anion gap having myeloma is 0.00026/0.0077, ie 0.034. Accordingly, 97% of patients with a low anion gap do not have myeloma and 'no intrinsic cost' becomes inflated by the 'need for more specific investigation'.
Multichannel continuous-flow analysers can produce a great deal of unsolicited data. Any procedure that extracts clinically useful information from this at no extra cost is worthwhile. The early diagnosis of myeloma is highly desirable. However, with a trend towards discretionary analysis, it is doubtful whether these figures justify the real cost of including the anion gap in a biochemical profile. JAMA 1980; 243:1737-8 Assessment of self-poisoning patients by psychiatrists and junior medical staff
Sir, The study of assessment in one particular casualty unit by Creed and Black (February 1988 JRSM, p 97) highlights the advantages and shortfalls in care of patients treated wholly in out-patient units as compared with those assessed while they are inpatients.
The challenge raised in the last paragraph could well be answered, to the advantage of all, by a nationwide duplication of the near-ideal system in Sunderland District General Hospital (catchment 350000 urban to 500 000 total, including hinterland) where all self-poisoning or self-harming patients are treated, for the acute situation, in the out-patient unit, swiftly admitted to the 22-bedded accident/emergency ward, maintained under (now fairly expert) ward nursing staff, and seen next day (or sooner if necessary) by the senior accident/emergency staff, consultants or senior registrars (that cadre which, on its own, services all ward practice). Later that day, or as soon as the patient is fit for interview, the duty psychiatrist (who is available 7 days a week) appends his opinion and advice including that on any further necessary care. This system has operated well for the past decade and has created a beneficial close liaison betwixt the emergency and psychiatric units. I commend this system and suggest that it spares fairly busy senior house officers in the casualty unit, who can spend the additional time necessary to elicit a fruitful psychiatric history.
A R Dow Consultant in Accident and Emergency Medicine
Sunderland District General Hospital
Smoking -a major cause of polycythaemia Sir, The paper by Aitchison and Russell (February 1988 JRSM, p 89) on smoking as a major cause of polycythaemia was a welcomeaddition to the extensive evidence which now exists regarding this important issue. For those not yet convinced, however, it would have been useful if they had briefly commented upon the mechanisms by which cigarette smoking might be having the effects they saw.
In smokers, occupation by carbon monoxide of binding sites on haemoglobin reduces the oxygen content of circulating blood at any given Po 2 • Carbon monoxide also increases the affinity for oxygen of the remaining haem sites; the haemoglobin-oxygen dissociation curve is left-shifted', and there are also changes in the shape of the curve-. Not only is the blood carrying less oxygen, it is also more reluctant to release that oxygen to the tissues. This reduced oxygen delivery to the renal oxygen sensor responsible for erythropoietin release" may result in polycythaemia. Although a reduced plasma volume is found in many smokers with a raised haematocrit, it is not a universal finding. The influence of alcohol on plasma volume and the ways in which smoking and drinking may together produce polycythaemia have been discussed elsewherev", and Aitchison and Russell do not report patterns of alcohol consumption in their patients. Nevertheless, this does not detract from the importance of their message that carboxyhaemoglobin estimation is a vital part of the investigation of patients with both absolute and relative polycythaemia. J MOORE·GILLON Br Med J 1986; 292:1617-8 Facial reconstruction in Down's syndrome Sir, I think some aspects of the editorial by Hatch (January 1988 JRSM, p 1) on the above subject, should not go unchallenged. I note that the author is an anaesthetist, and may therefore lack very much Journal of the Royal Society of Medicine Volume 81 July 1988 431 experience of the problems faced by the families of children and young people with Down's syndrome and by the young Down's syndrome people themselves. I take particular issue with his comment that, '... if there is severe mental impairment, it is hard to see how cosmetic surgery could help a child to contribute more to society or become more integrated in it.' What contribution to society, precisely, is required of a child? Do these social indications determine in any way whether a child who might benefit from plastic surgery is to receive it? Not all children with Down's syndrome are, by any means, 'severely' mentally retarded, and it has been felt for many years that the children's ready identification may lead to prejudice that may limit their experience oflife, hence the movement in the USA particularly, towards facial reconstruction.
Department of Respiratory Medicine
Noone should recommend any type of surgery without due consideration of its risks, and that aspect of the editorial is clearly important. However, there should be few anaesthetists who would not realize that a patient with Down's syndrome might well have associated congenital heart disease as well, and there are very few centres, hopefully, that would allow surgery to proceed without appropriate preoperative investigation. Any patient at anaesthetic risk from severe congenital heart disease should not remain unremarked.
The question of whether plastic surgery is likely to be of benefit or otherwise should be considered by the parents or other carers, by the young person if old enough to have an opinion, by his or her community or hospital paediatrician, and by the general practitioner and other professionals involved in health care, in consultation with a plastic surgeon who has had experience of this work. An anaesthetist should then be drawn in to consider the risks. This procedure should not be reversed. C G H NEWMAN
Consultant Paediatrician
Westminster Hospital, London *The author replies below: Sir, It is reassuring to know that Dr Newman agrees that cosmetic surgery should not be recommended to Down's syndrome patients without due consideration of the risks. The main purpose of the editorial was to remind those involved with the primary care of these patients how significant these risks can be. This is something which anaesthetists are perhaps uniquely placed to comment on, since not only are they intimately involved with the families at the time of operation, but they must also ultimately shoulder the responsibility of deciding whether or not the child is fit for surgery, and in many cases manage the intensive care problems which may arise afterwards even in the absence of congenital heart disease. Though most plastic surgeons take a very balanced view about this problem, some of the current literature suggests that it is not always easy for them to be entirely objective about the results of their surgery.
It is important for all concerned to have a realistic idea about the possible benefits of the proposed surgery to weigh against the risks. This is, surely, particularly important when there is severe mental handicap, denying the patient the opportunity to take part in the decision-making process as Dr Newman would wish. He seems unaware ofthe multidisciplinary
